Holland Capital has sold Dutch dermatology platform Mauritskliniek to Ufenau-backed Corius, nine months after an exit to Triton-owned Bergman was blocked by the competition authorities.
Holland exits Mauritskliniek in sale to PE-backed Corius
Most Popular
